State Street SPDR S&P Biotech ETF (XBI) — ()

Key Metrics

 

News

Final Trades: FTAI, ETN, COWZ, XBI

Published: by:
Sentiment: Neutral ()

The Investment Committee give you their top stocks to watch for the second half.

Read More
image for news Final Trades: FTAI, ETN, COWZ, XBI
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List

Published: by:
Sentiment: Positive ()

The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in the …

Read More
image for news 3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
Biotech ETF (XBI) Hits New 52-Week High

Published: by:
Sentiment: Positive ()

XBI hits a fresh 52-week high after a sharp rebound in biotech momentum fueled by favorable regulation, valuations and improving funding trends.

Read More
image for news Biotech ETF (XBI) Hits New 52-Week High
Final Trades: Taiwan Semi, HealthEquity, CBOE Global Markets and the XBI

Published: by:
Sentiment: Neutral ()

The Investment Committee give you their top stocks to watch for the second half.

Read More
image for news Final Trades: Taiwan Semi, HealthEquity, CBOE Global Markets and the XBI
3 Biotech Stocks I Am Accumulating

Published: by:
Sentiment: Positive ()

The biotech sector has underperformed the market for many years now, but there are reasons to be optimistic about this area of the market. Many biotech/biopharma stocks also make good …

Read More
image for news 3 Biotech Stocks I Am Accumulating
RTW Investments' Rod Wong: Expect more deals in biotech space

Published: by:
Sentiment: Positive ()

Rod Wong, RTW Investments CIO & Managing Director, joins CNBC's 'Money Movers' to discuss J&J's reported interest in buying Protagonist Therapeutics, whether he expects more consolidation in the sector, and …

Read More
image for news RTW Investments' Rod Wong: Expect more deals in biotech space
Trade Tracker: Joe Terranova buys more XBI

Published: by:
Sentiment: Positive ()

Joe Terranova, senior managing director at Virtus Investment Partners, joins CNBC's "Halftime Report" to explain why he's buying XBI again. The committee share their health care strategy.

Read More
image for news Trade Tracker: Joe Terranova buys more XBI
How to trade the health care break out

Published: by:
Sentiment: Positive ()

The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.

Read More
image for news How to trade the health care break out
XBI: Surprise Exit Of A Tough Regulator At The FDA

Published: by:
Sentiment: Neutral ()

XBI has rebounded over 20% since lows in April, despite changes at the FDA that could have signaled a tougher regulatory environment. Vinay Prasad was only appointed in May, but …

Read More
image for news XBI: Surprise Exit Of A Tough Regulator At The FDA
Trump threatens 50% tariffs on copper, 200% on pharmaceuticals

Published: by:
Sentiment: Neutral ()

However, the President did not disclose when the tariffs would take effect.

Read More
image for news Trump threatens 50% tariffs on copper, 200% on pharmaceuticals
Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet

Published: by:
Sentiment: Neutral ()

President Trump has announced today he plans to reduce U.S. drug prices by 30-80% via an Executive Order, targeting Big Pharma's high costs and profits. U.S. drug prices are significantly …

Read More
image for news Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet
Surprise Breakthrough: US-China Talks Spark Market Rally

Published: by:
Sentiment: Positive ()

An unexpected thaw in US-China trade relations is sending US equity markets soaring this morning.

Read More
image for news Surprise Breakthrough: US-China Talks Spark Market Rally
Trade Tracker: Joe Terranova sells the XBI, buys Amgen

Published: by:
Sentiment: Neutral ()

Joe Terranova, Senior Managing Director for Virtus Investment Partners, joins CNBC's "Halftime Report" to detail his latest portfolio moves.

Read More
image for news Trade Tracker: Joe Terranova sells the XBI, buys Amgen

About State Street SPDR S&P Biotech ETF XBI

The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing